Olon Strategies for Right First Time Scale Up

Recombinant DNA technology and chimeric protein expression to enhance the production of therapeutic peptides in microbial systems

NCF (Notiziario Chimico Farmaceutico): GLOBAL EXCELLENCE OF CDMO AND GENERIC API INDUSTRY – Interview with CEO Paolo Tubertini

Future of Pharma Insights: Q&A with Andrea Conforto

Assurance of supply: Olon Group’s strategy for times of geopolitical instability

CASE STUDY: Nucleophilic substitution of the nitro group in aromatic compound in flow conditions (V.Anzi)

High-resolution mass spectrometry: a powerful technology in drug discovery and process development

Olon publishes the White Paper “Olon case, Management of nitrosamine standards”

Olon has presented the abstract “When the catalyst reacts not only with your substrate” at the National Summit of Organic Chemistry Division (CDCO)

International Workshop on Sustainable Chemistry